Carbimazole-Resistant Grave’s Thyrotoxicosis is a Diagnostic and Therapeutic Dilemma, Case Report with Literature Review

References

• Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. P T. 2015;40(4):277–283.
   PubMedGoogle Scholar
• Ata F, Khan AA, Yousaf Z, et al. The clinical characteristics and outcomes of patients with pulmonary hypertension in association with hyperthyroid state: a systematic review. Medicine. 2022;101(26):e29832. doi:10.1097/MD.0000000000029832
   PubMed Web of Science ®Google Scholar
• Klein I, Danzi S. Thyroid disease and the heart. Circulation. 2007;116(15):1725–1735. doi:10.1161/CIRCULATIONAHA.106.678326
   PubMed Web of Science ®Google Scholar
• Li H, Okuda J, Akamizu T, Mori T. A hyperthyroid patient with Graves’ disease who was strongly resistant to methimazole: investigation on possible mechanisms of the resistance. Endocr J. 1995;42(5):697–704. doi:10.1507/endocrj.42.697
   PubMed Web of Science ®Google Scholar
• Jude EB, Dale J, Kumar S, Dodson PM. Treatment of thyrotoxicosis resistant to carbimazole with corticosteroids. Postgrad Med J. 1996;72(850):489–491.
   PubMed Web of Science ®Google Scholar
• Corvilain B, Schinohoritis P. Carbimazole--resistant thyrotoxicosis. Postgrad Med J. 1997;73(864):686. doi:10.1136/pgmj.73.864.686
   PubMed Web of Science ®Google Scholar
• Lee S, Kapoor D, Thomas W, Jones T. Thionamide resistant thyrotoxicosis - three illustrative cases. In: 24th Joint Meeting of the British Endocrine Societies; 2005.
   Google Scholar
• Sebastián-Ochoa A, Quesada-Charneco M, Fernández-García D, Reyes-García R, Rozas-Moreno P, Escobar-Jiménez F. Dramatic response to cholestyramine in a patient with Graves’ disease resistant to conventional therapy. Thyroid. 2008;18(10):1115–1117. doi:10.1089/thy.2008.0094
   PubMed Web of Science ®Google Scholar
• Saleem T, Sheikh A, Masood Q. Resistant thyrotoxicosis in a patient with Graves disease: a case report. J Thyroid Res. 2011;2011(649084):1–4. doi:10.4061/2011/649084
   Google Scholar
• Yang Y, Hwang S, Kim M, et al. Refractory Graves’ disease successfully cured by adjunctive cholestyramine and subsequent total thyroidectomy. Endocrinol Metab. 2015;30(4):620–625. doi:10.3803/EnM.2015.30.4.620
   Google Scholar
• Chae SB, Kim ES, Lee YI, Min BR. A case of methimazole-resistant severe Graves’ disease: dramatic response to cholestyramine. IJT. 2016;9(2):190–194.
   Google Scholar
• Nagi D, Holems S, Jenkins R. Thyrotoxicosis resistant to treatment: graves’ disease or Factitious thyrotoxicosis: a puzzle. In: Society for Endocrinology BES 2016; 2016.
   Google Scholar
• Ramtahal R, Dhanoo A. A case of Graves’ disease resistant to carbimazole. West Indian Med J. 2016;2016:266.
   Google Scholar
• Kim J, Kim TH. A methimazole resistant patient with Graves’ disease (GD): a case report of mid-term management with herbal decoctions mainly composed of Anemarrhena Bunge. Complement Ther Med. 2018;39:109–113. doi:10.1016/j.ctim.2018.05.015
   PubMed Web of Science ®Google Scholar
• Linardi A, Michou E, Ilias I, et al. Resistant thyrotoxicosis due to Graves’ disease in pregnancy: case report and review of the literature. Cureus. 2018;10(8):e3232. doi:10.7759/cureus.3232
   PubMed Web of Science ®Google Scholar
• Diack N, Ndiaye N, Sene M, et al. Resistance to anti-thyroid drugs in Graves’ disease: clinical-biological characteristics and alternative therapy in tropical area. Open J Endocr Metab Dis. 2020;10(11):147–153. doi:10.4236/ojemd.2020.1011014
   Google Scholar
• Lewandowski K, Dabrowska K, Gluchowska M, Lewinski A. Pulse methylprednisolone as preparation for thyroidectomy for drug-resistant amiodarone-induced thyrotoxicosis. In: Society for Endocrinology BES 2021; 2021.
   Google Scholar
• Mori Y, Hiromura M, Terasaki M, et al. Very rare case of Graves’ disease with resistance to methimazole: a case report and literature review. J Int Med Res. 2021;49(3):300060521996192. doi:10.1177/0300060521996192
   PubMed Web of Science ®Google Scholar
• Kamrul-Hasan AB, Mondal E. Carbimazole-resistant Graves’ disease responding to oral prednisolone: a case report. Mymensingh Med J. 2022;31(2):553–555.
   PubMedGoogle Scholar
• De Leo S, Lee SY, Braverman LE. Hyperthyroidism. Lancet. 2016;388(10047):906–918. doi:10.1016/S0140-6736(16)00278-6
   PubMed Web of Science ®Google Scholar
• Ross DS, Burch HB, Cooper DS. 2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26(10):1343–1421. doi:10.1089/thy.2016.0229
   PubMed Web of Science ®Google Scholar
• Trevor A, Katzung B, Masters S. Katzung & Trevor’s Pharmacology Examination and Board Review. 9th ed. McGraw-Hill Companies, Incorporated; 2010.
   Google Scholar
• Balla M, Jhingan RM, Rubin DJ. Rapid levothyroxine absorption testing: a case series of nonadherent patients. Int J Endocrinol Metab. 2015;13(4):e31051.
   PubMed Web of Science ®Google Scholar
• Addo B, Sencherey S, Babayara MNK. Medication noncompliance among patients with chronic diseases attending a primary health facility in a Periurban District in Ghana. Int J Chronic Dis. 2018;2018:7187284. doi:10.1155/2018/7187284
   PubMedGoogle Scholar
• Ye S, Krupka DJ, Davidson KW. Diagnosing medication non-adherence in a patient with myocardial infarction. Front Psychol. 2012;3:267. doi:10.3389/fpsyg.2012.00267
   PubMed Web of Science ®Google Scholar
• Jimmy B, Jose J. Patient medication adherence: measures in daily practice. Oman Med J. 2011;26(3):155–159. doi:10.5001/omj.2011.38
   PubMedGoogle Scholar
• Butov DO. Malabsorption syndromes in patients with tuberculosis as a cause of ineffective treatment: how to diagnose and overcome? Infusion Chemother. 2020;3.2:24–25.
   Google Scholar
• McQuaid CF, Horton KC, Dean AS, Knight GM, White RG. The risk of multidrug- or rifampicin-resistance in males versus females with tuberculosis. Eur Respir J. 2020;56(3):2000626. doi:10.1183/13993003.00626-2020
   PubMed Web of Science ®Google Scholar
• Al Hamdan AS, Alghamdi AA, Alyousif GF, et al. Evaluating the prevalence and the risk factors of gram-negative multi-drug resistant bacteria in Eastern Saudi Arabia. Infect Drug Resist. 2022;15:475–490. doi:10.2147/IDR.S350048
   PubMed Web of Science ®Google Scholar
• He Q, Dong H, Gong M, et al. New therapeutic horizon of Graves’ hyperthyroidism: treatment regimens based on immunology and ingredients from traditional Chinese medicine. Front Pharmacol. 2022;13:1.
   Web of Science ®Google Scholar